is a Shanghai-based manufacturer of peptide raw materials, Fmoc-protected amino acids, resin components, and bulk research and commercial-grade peptides that form the substrate inputs for SPPS manufacturing globally
Recommended Dosage and Protocol Guidelines Dosage varies by application and administration route: Skin Brightening Protocol: 6001500mg IV, 13 times per week for 812 weeks, followed by monthly maintenance Liver Detoxification Support: 6001200mg IV, 23 times per week for 48 weeks under medical supervision General Antioxidant Wellness: 600900mg IV weekly, or 5001000mg oral liposomal daily Athletic Recovery Protocol: 5001000mg IV post-training, or 500mg oral liposomal daily Heavy Metal Detox Support: 12001500mg IV, 23 times per week alongside medical chelation protocol Neurological Support Research: 10001400mg IV, frequency determined by supervising physician Reconstitution (IV use): Dissolve in 1020ml sterile saline for slow IV push over 1015 minutes Product Specifications Active Ingredient: Reduced L-Glutathione (GSH) Form: Lyophilized powder for IV reconstitution or oral liposomal capsule (variant dependent) Dose per Vial / Unit: 1500mg Purity: 99% pharmaceutical-grade (HPLC verified) Molecular Formula: CHNOS Molecular Weight: 307.32 g/mol Appearance: White crystalline lyophilized powder Solubility: Freely soluble in water and sterile saline Storage: Store at 28C
Every patient's tolerance is different, and personalization is the key to long-term success without discomfort
The fat loss mechanism works through GH-mediated lipolysis
Notably, a Medicare GLP-1 Bridge pilot begins July 1, 2026 with a $50 monthly copay for eligible enrollees a change from the old rule that Medicare never covered weight loss drugs
Thoughts on risks, market impact, and the future of GLP-1
